Table 6.
All Hospitalizations | Non-AIDS-Defining | Infectious Cause | Primary Surgical | |||||
---|---|---|---|---|---|---|---|---|
Factor | RR (95% CI) | p-value | RR (95% CI) | p-value | RR (95% CI) | p-value | RR (95% CI) | p-value |
Age, per 10 years | 1.08 (0.98–1.19) | 0.12 | 1.11 (1.00–1.21) | 0.05 | 0.96 (0.83–1.11) | 0.60 | 1.25 (1.06–1.48) | <0.01 |
| ||||||||
Gender, female vs. male | 1.34 (0.99–1.80) | 0.05 | 1.38 (1.04–1.83) | 0.02 | 0.71 (0.40–1.24) | 0.22 | 1.49 (0.95–2.35) | 0.08 |
| ||||||||
Race/ethnicity | ||||||||
African American vs. Caucasian | 0.88 (0.73–1.06) | 0.18 | 0.85 (0.71–1.02) | 0.09 | 1.09 (0.86–1.39) | 0.48 | 0.58 (0.41–0.81) | <0.01 |
Other vs. Caucasian | 1.01 (0.76–1.32) | 0.99 | 0.97 (0.74–1.27) | 0.84 | 0.95 (0.59–1.51) | 0.82 | 0.82 (0.50–1.34) | 0.42 |
| ||||||||
Chronic hepatitis B | 1.19 (0.82–1.71) | 0.36 | 1.23 (0.86–1.76) | 0.26 | 1.21 (0.80–1.81) | 0.37 | 1.31 (0.79–2.17) | 0.30 |
| ||||||||
Chronic hepatitis C | 1.46 (1.05–2.03) | 0.02 | 1.57 (1.13–2.20) | <0.01 | 0.97 (0.66–1.43) | 0.87 | 1.59 (0.99–2.55) | 0.06 |
| ||||||||
Nadir1 CD4 count, per 50 cells/mm3 | 0.92 (0.89–0.95) | <0.01 | 0.94 (0.91–0.97) | <0.01 | 0.86 (0.82–0.91) | <0.01 | 1.03 (0.98–1.09) | 0.28 |
| ||||||||
Proximal CD4 count | ||||||||
350–499 vs. <350 | 0.71 (0.59–0.86) | <0.01 | 0.75 (0.62–0.91) | <0.01 | 0.67 (0.51–0.89) | <0.01 | 0.92 (0.60–1.41) | 0.69 |
≥500 vs. <350 | 0.67 (0.56–0.81) | <0.01 | 0.70 (0.58–0.84) | <0.01 | 0.56 (0.44–0.72) | <0.01 | 0.82 (0.54–1.25) | 0.36 |
| ||||||||
Receipt of HAART 2 | ||||||||
At CD4 <350 | 0.72 (0.55–0.94) | 0.02 | 0.73 (0.54–0.97) | 0.03 | 0.62 (0.45–0.84) | <0.01 | 1.71 (0.69–4.22) | 0.25 |
At CD4 350–499 | 0.81 (0.53–1.24) | 0.33 | 0.81 (0.52–1.26) | 0.35 | 0.58 (0.34–0.99) | 0.05 | 1.09 (0.50–2.37) | 0.83 |
At CD4 ≥500 | 1.06 (0.79–1.41) | 0.71 | 1.01 (0.76–1.32) | 0.97 | 1.34 (0.85–2.10) | 0.21 | 0.79 (0.48–1.31) | 0.35 |
| ||||||||
HAART × CD4 level interaction | 0.13 | 0.30 | 0.07 | 0.13 |
Nadir represents the lowest CD4 count from HIV diagnosis through the prior year to hospitalization
Results from separate analyses for proximal CD4 levels < 350, 350–499, and 500+ including same covariates. RR, relative rate